Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

Wang, Zhongliang, Yang, Bohan, Li, Qianwen, Wen, Lu, Zhang, Ruiguang·2020·Clinical Infectious Diseases
DOI 10.1093/cid/ciaa272

Cited by (1,001)

Items 101–200 of 1,001

  1. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
    Amirhossein Hessami, Amir Shamshirian, Keyvan Heydari, Fatemeh Pourali, Reza Alizadeh‐Navaei, Mahmood Moosazadeh, Saeed Abrotan, Layla Shojaie, Sogol Sedighi, Danial Shamshirian et al. · 2020 · The American Journal of Emergency Medicine
  2. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
    Gopal S. Gupta · 2022 · Inflammation
  3. O Coração e a COVID-19: O que o Cardiologista Precisa Saber
    Isabela Bispo Santos da Silva Costa, Cristina Salvadori Bittar, Stéphanie Itala Rizk, Antônio Everaldo de Araújo, Kelly Karoline Medeiros dos Santos, Theuran Inahja Vicente Machado, Fernanda Thereza de Almeida Andrade, Thalita Barbosa González, Andrea Nataly Galarza Arévalo, Juliano Pinheiro de Almeida et al. · 2020 · Arquivos Brasileiros de Cardiologia
  4. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
    Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda Ferreira Cruz, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Marcelo Marcos Morales, Celso Caruso Neves, Patrícia R. M. Rocco · 2021 · Frontiers in Physiology
  5. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic
    Karyne Rangel, Thiago Pavoni Gomes Chagas, Salvatore G. De-Simone · 2021 · Pathogens
  6. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
    Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni · 2020 · Liver International
  7. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)
    Célestin Danwang, Francky Teddy Endomba, Jan René Nkeck, Dominic Leandry Angong Wouna, Annie R Robert, Jean Jacques Noubiap · 2020 · Biomarker Research
  8. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
    Christine J. Kubin, Thomas Howe McConville, Donald Dietz, Jason E Zucker, Michael S. May, Brian C. Nelson, Elizabeth Istorico, Logan Bartram, Jennifer L. Small-Saunders, Magdalena E. Sobieszczyk et al. · 2021 · Open Forum Infectious Diseases
  9. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
    Saeed K Alzghari, Valerie S. Acuña · 2020 · Journal of Clinical Virology
  10. Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy
    Andrea Borghesi, Angelo Zigliani, Salvatore Golemi, Nicola Carapella, Patrizia Maculotti, Davide Farina, Roberto Maroldi · 2020 · International Journal of Infectious Diseases
  11. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis
    Ana Macedo, Nilza Gonçalves, Cláudia Febra · 2021 · Annals of Epidemiology
  12. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis
    Catherine Ruth Jutzeler, Lucie Bourguignon, Caroline Weis, Bobo Tong, Cyrus Wong, Bastian Rieck, Hans Pargger, Sarah Tschudin‐Sutter, Adrian Egli, Karsten Michael Borgwardt et al. · 2020 · Travel Medicine and Infectious Disease
  13. Can Zn Be a Critical Element in COVID-19 Treatment?
    Mohammad Tariqur Rahman, Syed Zahir Idid Syed Osman Idid · 2020 · Biological Trace Element Research
  14. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis
    Ana Karla Guedes de Melo, Keilla Martins Milby, Ana Luíza Mendes Amorim Caparroz, Ana Carolina Pereira Nunes Pinto, Rodolfo Rodrigo Pereira Santos, Aline Pereira da Rocha, Gilda Aparecida Ferreira, Viviane Angelina de Souza, Lílian David de Azevedo Valadares, Rejane Maria Rodrigues de Abreu Vieira et al. · 2021 · PLoS ONE
  15. Liver diseases in COVID-19: Etiology, treatment and prognosis
    Jian Wu, Shu Song, Hongcui Cao, Lan-Juan Li · 2020 · World Journal of Gastroenterology
  16. Pathogenesis of Respiratory Viral and Fungal Coinfections
    Fabián Salazar, Elaine Bignell, Gordon D. Brown, Peter C. Cook, Adilia Warris · 2021 · Clinical Microbiology Reviews
  17. Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
    Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, María Victoria Salgado, Héctor Miguel Vetulli, Analía Aquieri, Francisco Azzato, Mauro Basconcel, Marcela Castro, Javier Coyle et al. · 2021 · EClinicalMedicine
  18. Bacterial infections and patterns of antibiotic use in patients with COVID‐19
    Alvaro Goncalves Mendes Neto, Kevin Bryan Lo, Ammaar Wattoo, Grace Salacup, Jerald Pelayo, Robert DeJoy, Ruchika Bhargav, Fahad Gul, Eric L. Peterson, Jeri Albano et al. · 2020 · Journal of Medical Virology
  19. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China
    Rong Zhi Yang, Hui Mei, Tongzhang Zheng, Qiang John Fu, Yiming Zhang, Stephen L. Buka, Xinan Yao, Zezhong Tang, Xichi Zhang, Lin Qiu et al. · 2020 · BMC Medicine
  20. Liver injury is associated with severe coronavirus disease 2019 (COVID‐19) infection: A systematic review and meta‐analysis of retrospective studies
    Mohammad Parohan, Sajad Yaghoubi, Asal Seraj · 2020 · Hepatology Research
  21. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship
    Kathrin Rothe, Susanne Feihl, Jochen Schneider, Fabian Wallnöfer, Milena Wurst, Marina Lukas, Matthias Treiber, Tobias Lahmer, Markus H. Heim, Michael Dommasch et al. · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
  22. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
    Ribeiro, Deidiane Elisa, Oliveira-Giacomelli, Ágatha, Glaser, Talita, Arnaud-Sampaio, Vanessa F., Andrejew, Roberta, Dieckmann, Luiz, Baranova, Juliana, Lameu, Claudiana, Ratajczak, Mariusz Z., Ulrich, Henning · 2021 · Molecular Psychiatry
  23. The Risk and Prognosis of COVID-19 Infection in Cancer Patients
    Ghada Metwally ElGohary, Shahrukh Khurshid Hashmi, Jan Styczyński, Mohamed A. Kharfan‐Dabaja, Rehab M. Alblooshi, Rafael de la Cámara, Sherif Mohmed, Alfadel Alshaibani, Simone Cesaro, Nashwa Abd El-Aziz et al. · 2020 · Hematology/Oncology and Stem Cell Therapy
  24. Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
    Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, Pejman Mokhtari, Maryam Nemati · 2020 · Scandinavian Journal of Immunology
  25. Curcumin (a constituent of turmeric): New treatment option against COVID‐19
    Fatemeh Babaei, Marjan Nassiri‐Asl, Hossein Hosseinzadeh · 2020 · Food Science & Nutrition
  26. On the molecular determinants of the SARS-CoV-2 attack
    Darja Kanduc, Yehuda Shoenfeld · 2020 · Clinical Immunology
  27. SARS-CoV-2 and COVID-19: From the Bench to the Bedside
    Stefano Romagnoli, Adriano Peris, Angelo Raffaele De Gaudio, Pierangelo Geppetti · 2020 · Physiological Reviews
  28. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis.
    Brandon Michael Henry, Isaac Cheruiyot, Jens Vikse, Victor Mutua, Vincent Kipkorir, Justin L. Benoit, Mario Plebani, Nicola Luigi Bragazzi, Giuseppe Lippi · 2020 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  29. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 Via Breathing, Speaking, Singing, Coughing, and Sneezing
    Schijven, Jack, Vermeulen, Lucie C., Swart, Arno, Meijer, Adam, Duizer, Erwin, de Roda Husman, Ana Maria · 2021 · Environmental Health Perspectives
  30. COVID-19 and MS disease-modifying therapies
    Joseph R. Berger, Rachel Brandstadter, Amit Bar‐Or · 2020 · Neurology Neuroimmunology & Neuroinflammation
  31. Cancer associates with risk and severe events of <scp>COVID</scp> ‐19: A systematic review and meta‐analysis
    Tian, Yehong, Qiu, Xiaowei, Wang, Chengxiang, Zhao, Jianxin, Jiang, Xin, Niu, Wenquan, Huang, Jinchang, Zhang, Fengyu · 2021 · International Journal of Cancer
  32. COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
    Giuseppe Magro · 2020 · Virus Research
  33. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
    Upendra Katneni, Aikaterini Alexaki, Ryan Hunt, Tal Schiller, Michael N. DiCuccio, Paul W. Buehler, Juan C. Ibla, Chava Kimchi‐Sarfaty · 2020 · Thrombosis and Haemostasis
  34. Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
    Ting Wu, Zhihong Zuo, Shuntong Kang, Liping Jiang, Xuan Luo, Zanxian Xia, Jing Liu, Xiaojuan Xiao, Mao Ye, Meichun Deng · 2020 · Aging and Disease
  35. Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis
    Miloš Jeseňák, Miroslava Brndiarová, Ingrid Urbančíková, Zuzana Rennerová, Jarmila Vojtková, Anna Bobčáková, Róbert Ostró, Peter Bánovčin · 2020 · Frontiers in Cellular and Infection Microbiology
  36. Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China
    Ting Ding, Jinjin Zhang, Tian Wang, Pengfei Cui, Zhe Chen, Jingjing Jiang, Su Zhou, Jun Dai, Bo Wang, Suzhen Yuan et al. · 2020 · Clinical Infectious Diseases
  37. The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Evgeny Lvovich Nasonov, Samsonov MIu · 2020 · Biomedicine & Pharmacotherapy
  38. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
    Angelo Silverio, Marco Di Maio, Rodolfo Citro, Luca Esposito, Giuseppe Iuliano, Michele Bellino, Cesare Baldi, Giuseppe De Luca, Michele Ciccarelli, Carmine Vecchione et al. · 2021 · BMC Cardiovascular Disorders
  39. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
    Jude Moutchia, Pratik Pokharel, Aldiona Kerri, Kaodi McGaw, Shreeshti Uchai, Miriam Nji, Michael G Goodman · 2020 · PLoS ONE
  40. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis
    Omar Ariel Espinosa, A Zanetti, Ednardo Fornanciari Antunes, Fabiana Gulin Longhi, Tatiane Amorim de Matos, Paula Franciene Battaglini · 2020 · Revista do Instituto de Medicina Tropical de São Paulo
  41. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis
    Roshan Kumar Mahat, Suchismita Panda, Vedika Rathore, Sharmistha Swain, Lalendra Yadav, Saraswati Sah · 2021 · Clinical Epidemiology and Global Health
  42. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
    Bakiye Göker Bağca, Çığır Biray Avcı · 2020 · Cytokine & Growth Factor Reviews
  43. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
    Dong Huang, He Yu, Ting Wang, Huan Yang, R. Yao, Zong-An Liang · 2020 · Journal of Medical Virology
  44. Role of Mitochondria in Viral Infections
    Srikanth Elesela, Nicholas W. Lukacs · 2021 · Life
  45. Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis.
    A. Baradaran, M. Ebrahimzadeh, A. Baradaran, A. Kachooei · 2020 · The Archives of Bone & Joint Surgery
  46. SARS-CoV-2 infection in children
    Haluk Cezmi Çokuğraş, Pınar Önal · 2020 · Turkish Archives of Pediatrics
  47. Hematological Abnormalities in COVID-19: A Narrative Review
    Asma Rahman, Roshan Niloofa, Umesh Jayarajah, Sanjay De Mel, Visula Abeysuriya, Suranjith Luke Seneviratne · 2021 · American Journal of Tropical Medicine and Hygiene
  48. Possibility of magnesium supplementation for supportive treatment in patients with COVID-19
    Chuanfeng Tang, Hong Ding, Rui‐Qing Jiao, Xingxin Wu, Ling‐Dong Kong · 2020 · European Journal of Pharmacology
  49. Current Strategies of Antiviral Drug Discovery for COVID-19
    Miao Mei, Xu Tan · 2021 · Frontiers in Molecular Biosciences
  50. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
  51. COVID-19: from epidemiology to treatment
    Juan Manuel Pericàs, Marta Hernández‐Meneses, Timothy Patrick Sheahan, Eduard Quintana, Juan Ambrosioni, Elena Sandoval, Carlos Falces, María Ángeles Marcos, Montserrat Tuset, Anna Vilella et al. · 2020 · European Heart Journal
  52. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
    Wenhao Niu, Feng Wu, Wen-yue Cao, Zonggui Wu, Yu-Chieh Chao, Fei Peng, Chun Liang · 2020 · Bioscience Reports
  53. SARS-CoV-2 infections in children and young people
    Susanna Felsenstein, Christian Michael Hedrich · 2020 · Clinical Immunology
  54. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
    Adam F. Feyaerts, Walter H. M. L. Luyten · 2020 · Nutrition
  55. COVID-19, cytokines, inflammation, and spices: How are they related?
    Ajaikumar Bahulayan Kunnumakkara, Varsha Rana, Dey Parama, Kishore Banik, Sosmitha Girisa, Sahu Henamayee, Krishan Kumar Thakur, Uma Dutta, Prachi Garodia, Subash C. Gupta et al. · 2021 · Life Sciences
  56. Smoking and COVID-19: Adding Fuel to the Flame
    Vivek Kumar Kashyap, Anupam Dhasmana, Andrew E. Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, Murali Mohan Yallapu, Subhash C. Chauhan · 2020 · International Journal of Molecular Sciences
  57. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
    Anna Artese, Valentina Svicher, Giosuè Costa, Romina Salpini, Velia Chiara Di Maio, Mohammad Alkhatib, Francesca Alessandra Ambrosio, Maria Mercedes Santoro, Yehuda G. Assaraf, Stefano Alcaro et al. · 2020 · Drug Resistance Updates
  58. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
    Shamshul Ansari, John Philip Hays, Andrew Haddon Kemp, Raymond C. Okechukwu, Jayaseelan Murugaiyan, Mutshiene Deogratias Ekwanzala, Maria Josefina Ruiz Alvarez, Maneesh Paul Satyaseela, Chidozie Declan Iwu, Clara Ballesté‐Delpierre et al. · 2021 · JAC-Antimicrobial Resistance
  59. Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
    Artur Słomka, Mariusz Kowalewski, Ewa Żekanowska · 2020 · Pathogens
  60. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
    Tewodros Shibabaw · 2020 · Journal of Inflammation Research
  61. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) – A drug repurposing study
    Jamshaid Ahmad, Saima Ikram, Fawad Ahmad, Irshad Ur Rehman, Maryam Mushtaq · 2020 · Heliyon
  62. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality
    Seshadri Reddy Varikasuvu, Naveen Dutt, Balachandar Thangappazham, Saurabh Varshney · 2020 · Primary care diabetes
  63. Monitoring the COVID-19 epidemic in the context of widespread local transmission
    Alberto L. García‐Basteiro, Carlos Chaccour, Caterina Guinovart, Anna Llupià, Joe Brew, Antoni Trilla, Antoni Plasència · 2020 · The Lancet Respiratory Medicine
  64. Science-Based Strategies of Antiviral Coatings with Viricidal Properties for the COVID-19 Like Pandemics
    Rakesh Pemmada, Xiaoxian Zhu, Madhusmita Dash, Yubin Zhou, Seeram Ramakrishna, Xinsheng Peng, Vinoy Thomas, Sanjeev Jain, Himansu Sekhar Nanda · 2020 · Materials
  65. Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR
    Sama Rezasoltani, Abbas Yadegar, Behzad Hatami, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali · 2020 · Frontiers in Microbiology
  66. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit
    Siyuan Yang, Mingxi Hua, Xinzhe Liu, Chunjing Du, Lin Pu, Pan Xiang, Linghang Wang, Jingyuan Liu · 2021 · Microbes and Infection
  67. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients
    Philipp K. Buehler, Annelies Sophie Zinkernagel, Daniel A. Hofmaenner, Pedro David Wendel‐Garcia, Claudio Acevedo, Alejandro Gómez-Mejía, Srikanth Mairpady Shambat, Federica Andreoni, Martina A. Maibach, Jan Bartussek et al. · 2021 · Cell Reports Medicine
  68. Case Fatality Rate of COVID-19: A Systematic Review and Meta-Analysis
    Mojtaba Sepandi, Yousef Alimohamadi, Hailu Tola, Habteyes, Abbas Abbasi-Ghahramanloo, Majid Janani · 2020 · Journal of preventive medicine and hygiene
  69. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
    Mobina Fathi, Kimia Ghazi Vakili, Fatemeh Sayehmiri, Ashraf Mohamadkhani, Mohammadreza Hajiesmaeili, Mostafa Rezaei–Tavirani, Owrang Eilami · 2021 · PLoS ONE
  70. Machine learning methods to predict mechanical ventilation and mortality in patients with COVID-19
    Limin Yu, Alexandra Halalau, Bhavin Dalal, Amr E. Abbas, Felicia A. Ivascu, Mitual Amin, GIRISH BALACHANDRAN NAIR · 2021 · PLoS ONE
  71. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19
    Sachin J. Shah, Peter N. Barish, Priya A. Prasad, Amy L. Kistler, Norma F Neff, Jack Kamm, Lucy M. Li, Charles Y. Chiu, Jennifer M. Babik, Margaret C. Fang et al. · 2020 · EClinicalMedicine
  72. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
    Jilei Zhang, Shari Garrett, Jun Sun · 2020 · Genes and Diseases
  73. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis
    Brandon Michael Henry, Maria Helena Santos de Oliveira, Justin L. Benoit, Giuseppe Lippi · 2020 · Internal and Emergency Medicine
  74. COVID-19 associated invasive candidiasis
    Abdullah M. S. Al‐Hatmi, Jalila Mohsin, Aisha Al Huraizi, Faryal Ali Khamis · 2020 · Journal of Infection
  75. Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
    Alessandra Vultaggio, Ioana Octavia Agache, Cezmi A. Akdiş, Mübeccel Akdiş, Sevim Bavbek, Apostolos Bossios, Jean Bousquet, Onur Boyman, Adam M. Chaker, Susan Chan et al. · 2020 · Allergy
  76. Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?
    Vassilios Papadopoulos, Lu Li, Mary Katherine Samplaski · 2020 · Andrology
  77. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
    Mohamed A. Helal, Shaimaa Shouman, Ahmad Abdelwaly, Ahmed Osama Elmehrath, Mohamed Essawy, Shireen M. Sayed, Amr Hany Saleh, Nagwa El‐Badri · 2020 · Journal of Biomolecular Structure and Dynamics
  78. Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt
    Haidi Karam‐Allah Ramadan, Manal A. Mahmoud, Aburahma MZ, Amal A. Elkhawaga, Mohamed A. El‐Mokhtar, Ibrahim M. Sayed, Amal Mohammed Hosni, Sahar Mohamed Hassany, Mohammed Ahmed Medhat · 2020 · Infection and Drug Resistance
  79. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis
    Xiaohui Liu, Hongwei Wang, Si Shi, Jinling Xiao · 2021 · Postgraduate Medical Journal
  80. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
    C. Ogega, Nicole E. Skinner, P. Blair, Han-Sol Park, Kirsten Littlefield, A. Ganesan, S. Dhakal, Pranay Ladiwala, A. Antar, S. Ray et al. · 2021 · Journal of Clinical Investigation
  81. COVID-19 and anosmia in Tehran, Iran
    Sapideh Gilani, Rachel E. Roditi, Mohsen Naraghi · 2020 · Medical Hypotheses
  82. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
    Xinni Xu, Yew Kwang Ong, De Yun Wang · 2020 · Military Medical Research
  83. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
    Rundong Qin, Li He, Zhaowei Yang, Nan Jia, Ruchong Chen, Jiaxing Xie, Wanyi Fu, Hao Chen, Xinliu Lin, Renbin Huang et al. · 2022 · Clinical Reviews in Allergy & Immunology
  84. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
    Fernanda Irene Arnaldez, Steven J O'Day, Charles G. Drake, Bernard A. Fox, Bingqing Fu, Walter John Urba, Vincenzo Montesarchio, Jeffrey S. Weber, Haiming Wei, Jon M. Wigginton et al. · 2020 · Journal for ImmunoTherapy of Cancer
  85. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review
    Sheng-Ta Tsai, Ming‐Kuei Lu, Shao San, Chon‐Haw Tsai · 2020 · Frontiers in Neurology
  86. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review
    Awadhesh Kumar Singh, Kamlesh K. Khunti · 2020 · Diabetes Research and Clinical Practice
  87. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
    Brian Edward Dixon, Kara Wools‐Kaloustian, William F. Fadel, Thomas J. Duszynski, Constantin Theodore Yiannoutsos, Paul K. Halverson, Nir Menachemi · 2021 · PLoS ONE
  88. Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review
    Chanyan Huang, Jalal Soleimani, Svetlana Herasevich, Yuliya Pinevich, Kelly M. Pennington, Yue Dong, Brian W. Pickering, Amelia K. Barwise · 2020 · Mayo Clinic Proceedings
  89. Gender differences in patients with COVID-19: a narrative review
    Immacolata Ambrosino, Elena Barbagelata, Elena Ortona, Anna Ruggieri, Grace Massiah, Orazio Valerio Giannico, Cecilia Politi, Anna Maria Moretti · 2020 · Monaldi Archives for Chest Disease
  90. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-
    Cosmo Godino, Andrea Scotti, Norma Maugeri, Nicasio Mancini, Evgeny V. Fominskiy, Alberto Margonato, Giovanni Landoni · 2020 · International Journal of Cardiology
  91. Coronaviruses and the Chemical Senses: Past, Present, and Future
    Robert Pellegrino, Keiland W Cooper, Antonella Di Pizio, Paule V. Joseph, Surabhi Bhutani, Valentina Parma · 2020 · Chemical Senses
  92. Remote health diagnosis and monitoring in the time of COVID-19
    Behar, Joachim A, Liu, Chengyu, Kotzen, Kevin, Tsutsui, Kenta, Corino, Valentina D A, Singh, Janmajay, Pimentel, Marco A F, Warrick, Philip, Zaunseder, Sebastian, Andreotti, Fernando et al. · 2020 · Physiological Measurement
  93. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
    Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan · 2020 · Reviews in Medical Virology
  94. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports
    Rema Sreenivasan Soumya, T. Govindan Unni, Kozhiparambil Gopalan Raghu · 2020 · Cardiovascular Drugs and Therapy
  95. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature
    Konstantinos A. A. Douglas, Vivian Paraskevi Douglas, Marilita M Moschos · 2020 · In Vivo
  96. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
    Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed Ali Alrashed, Abdullah AlJuryyan, Mushira A. Enani, Faris Q Alenzi, Wael Alturaiki · 2021 · Frontiers in Immunology
  97. Emergence of environmental antibiotic resistance: Mechanism, monitoring and management
    Shishir Bobate, Sejal Mahalle, Nishant A. Dafale, Abhay Bajaj · 2023 · Environmental Advances
  98. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France
    Timothée Klopfenstein, H. Zahra, N’dri Juliette Kadiane-Oussou, Quentin Lepiller, Pierre-Yves Royer, Lynda Toko, Vincent Gendrin, Souheil Zayet · 2020 · International Journal of Infectious Diseases
  99. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
    Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna Carmela De Rosa et al. · 2020 · Journal for ImmunoTherapy of Cancer
  100. SARS Cov-2 infection in a renal-transplanted patient: A case report
    Elena Maria Seminari, Marta Colaneri, Margherita Sambo, Ilaria Gallazzi, Angela Maria Di Matteo, Silvia Roda, Raffaele Bruno · 2020 · American Journal of Transplantation